Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Effects on Immune Cells of a New 1,8-Naphthyridin-2-One Derivative and Its Analogues as Selective CB2 Agonists: Implications in Multiple Sclerosis.
Non-steroidal anti-inflammatory drug indometacin enhances endogenous remyelination.
Mast Cell-Mediated Inhibition of Abdominal Neutrophil Inflammation by a PEGylated TLR7 Ligand.
[Neuromyelitis optica spectrum disorder: a case report].
The natural history of multiple sclerosis: a geographically based study 10: relapses and long-term disability.
The roles of cathelicidin LL-37 in immune defences and novel clinical applications.
Ibuprofen-induced unilateral optic neuritis.
[The use of modern neuroimaging methods in studies of mechanisms of development cognitive disturbances in patients with multiple sclerosis].
The influence of tetracyclines on T cell activation.
Decreased signal transducers and activators of transcription (STAT) protein expression in lymphatic organs during EAE development in mice.
Increased risk of multiple sclerosis relapse after in vitro fertilisation.
Fingolimod therapy modulates circulating B cell composition, increases B regulatory subsets and production of IL-10 and TGFβ in patients with Multiple Sclerosis.
Idiopathic inflammatory demyelinating diseases of the central nervous system in patients following allogeneic hematopoietic stem cell transplantation: a retrospective analysis of incidence, risk factors and survival.
Multiple Sclerosis and Venous Abnormalities: Medicine in the Age of Social Media.
Management of Spasticity in Progressive Multiple Sclerosis: Efficacy of Repeated Intrathecal Triamcinolone Acetonide Administration.
Humoral mechanisms in T cell vaccination: induction and functional characterization of anti-lymphocytic autoantibodies.
[Autoimmune hepatitis in a patient with multiple sclerosis under treatment with glatiramer acetate].
Combination treatment of Glatiramer Acetate and Minocycline affects phenotype expression of blood monocyte-derived dendritic cells in Multiple Sclerosis patients.
Immune cells after prolonged Natalizumab therapy: implications for effectiveness and safety.
Hormone and immune system interactions in demyelinating disease.
Bilateral hearing loss as a manifestation of neuromyelitis optica.
β-Lapachone ameliorization of experimental autoimmune encephalomyelitis.
Stress as a risk factor for multiple sclerosis onset or relapse: a systematic review.
Chlamydia pneumoniae infection of the central nervous system in multiple sclerosis.
Rebif Advanced Magnetic Resonance Imaging (MRI) and Immunology Pilot Trial
Pages
« first
‹ previous
…
169
170
171
172
173
174
175
176
177
…
next ›
last »